Alan Chant, Director
Alan Chant joined the Myeloma UK Board of Directors in 2019.
Alan was diagnosed with myeloma in 2011, since then he has worked with Myeloma UK as a member of Support Groups, spoken at Infodays, been a member of research panels and a patient expert on NICE technical appraisals. He was also a patient representative on the 2016 NICE Myeloma Guidelines.
He is also currently a patient representative on other cancer bodies (NCRI Trustee and member or their Haematology & Oncology Group, UK Myeloma Research Academy, Cancer Research UK and Oxford Oncology Clinical Trials Office), other research organisations (including Oxford Biomedical Research Centre, UKCRC, Wellcome Trust and NIHR funding bodies) and is a Trustee on Oxford University Hospitals Charity.
Alan has over 40 years’ business experience, including 22 years at director level in large national consumer-focused companies including Sainsburys, Beecham, United Biscuits and Seagram. He was principally responsible for marketing and corporate development and was involved in the launch and development of the UK National Lottery.
Alan said “I am delighted to be joining the Myeloma UK Board, and extending my involvement with the charity. Myeloma UK is an impressive organisation that puts the needs of myeloma patients foremost in everything they do. The staff bring enthusiasm, passion and commitment to their roles. It is a privilege to be playing an enlarged role with them.”